A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

Stopped The trial did not meet its primary endpoint, hence was terminated due to futility.

Conditions

• Pulmonary Fibrosis
• Pulmonary Hypertension

Interventions

• COMBINATION_PRODUCT: INOpulse®
• COMBINATION_PRODUCT: Placebo
• COMBINATION_PRODUCT: Open Label Extension

Sponsor

Bellerophon Pulse Technologies